Solvias

Missed our recent webinars? We got you covered! In case you couldn't join us live, we're excited to announce that both of our recent webinars are now available on demand! 💻 Strategies for Determining Critical Quality Attributes of Nucleic Acid Therapeutics and Their Carriers 🔗 https://lnkd.in/e9fUHbZs 💻 De-risking and Accelerating Small Molecule Development, from Whiteboard to First-in-Human 🔗 https://lnkd.in/edvuDS4s Don’t miss these valuable opportunities to gain expert knowledge and stay ahead in the field. Watch them at your convenience and share with your network! #Solvias #Webinar #SmallMoleculeDevelopment #Pharmaceuticals #Biotechnology

☂ We are delighted to announce that Cergentis is now officially under the Solvias brand umbrella, as Solvias NL! This rebranding reaffirms our commitment to quality, safety, and innovation in biologics and cell and gene therapies. Solvias NL will continue to provide the high-quality data and customer service you know and trust, now with enhanced capabilities and a unified brand identity. We are excited about the possibilities that lie ahead and are fully committed to contributing to the global success of our customers. Learn more: https://lnkd.in/eJmRUnuR #Cergentis #Solvias #analyticalservices #CGT #genetherapies

Did you know that compliance with USP <665> is expected by 2026? This chapter provides crucial guidance on the analytical testing of single-use systems (SUS) to mitigate risks associated with extractables and leachables (E&L). With the deadline fast approaching, it's essential for drug developers to start preparing now. Download our white paper with comprehensive insights on USP <665> compliance. Get expert insights, detailed risk assessments, and practical steps for seamless compliance. Unlock the full document: https://lnkd.in/efB9nPUD

Join us at the PDA - Parenteral Drug Association Virus Conference in Amsterdam starting tomorrow! We’re excited to present our poster titled “Risk Mitigation of Usutu Virus Contamination in Raw Materials and Cell Lines for Biopharmaceutical Products Using Classical In Vitro Adventitious Virus Assay”. 🤝 Our team members Arnoud Boot, PhD, Melanie Schmiedl, Florian W., and Donna McMutrie are eager to discuss viral safety strategies for pharmaceutical products. Meet them at our poster or contact them directly to schedule a meeting. #PDAVirusConference #Biosafety #VirusSafety #ICHQ5A

We're excited to be at Chemspec Europe - Int. Exhibition for Fine & Speciality Chemicals, showcasing our cutting-edge solutions to bring your innovation to its destination. Marc Müller, Florian B., Vania Santana, and Norberto Bonalumi are ready to connect and discuss how we can support your projects. Stop by booth B20 to meet our experts. 📅 June 19-20, 2024 📍 Booth B20 #ChemspecEurope

Our new Cell & Gene Therapy Center of Excellence in RTP, North Carolina, is making headlines! North Carolina Biotechnology Center (NCBiotech)'s article spotlights Solvias' expansion and features insights from our U.S. General Manager, Steve Smith. Read full article below! #Solvias #CellTherapy #GeneTherapy #RTP #CGT

🕒 The countdown is on! Don't miss our upcoming webinar on June 18. Secure your spot now and learn how to bring your groundbreaking treatments from concept to clinic efficiently and effectively. 🔗 Register now: https://lnkd.in/e2zQ7435 What you will learn: ✔️Mitigate risks: learn about typical pitfalls most developers should avoid ✔️Timelines: gain insights on bottlenecks, and set up clear milestones ✔️Maximize efficiency: consulting with experts to bridge the compliance knowledge ✔️Cost-Effective Solutions: Explore alternative GMP manufacturing options that fit smaller budgets. #Solvias #PharmaDevelopment #DrugDevelopment #Webinar #Biotech #GMP

Did you know? At Solvias, we've implemented an innovative workflow to accelerate catalysis project development. Our state-of-the-art automation streamlines processes, reduces costs, and boosts productivity. Curious to learn more about our work with catalysis? Check these out: 📰 Article: Towards the Industrial Implementation of Mn-based Catalyst for the Hydrogenation of Ketones and Carboxylic Esters 🔗 https://lnkd.in/eYgqsfpB 💻 Webinar: The Journey of a Catalyst 🔗 https://lnkd.in/eGnaqdiC Contact us to discover how our workflow can help you bring your innovation to its destination: info@solvias.com #Catalysis #Automation #drugdevelopment #pharma #catalysts

Did you know that 70-90% of drugs in development face poor solubility and bioavailability? Amorphous solid dispersions (ASDs) are a proven solution to these challenges. However, the molecular interplay between drug substance and carrier in ASDs presents unique issues, particularly with crystallization and stability. Solvias' white paper explores these complexities in depth. Gain invaluable insights into ASD formulation and robust strategies for testing, quality assurance, and regulatory approval. Unlock the full document: https://lnkd.in/emN7YZrZ

What a fantastic way to celebrate World Environment Day! We are proud to announce that Solvias has been awarded the highest level of certification (Green) by My Green Lab, achieving an outstanding score of 84%! This certification, recognized as the gold standard for laboratory sustainability practices, involved a thorough assessment of our lab operations, equipment, waste management, and procurement processes. Laboratories are resource-intensive environments, and this prestigious recognition underscores our dedication to reducing the environmental impact of our work. Thank you to everyone at Solvias who contributed to this remarkable achievement! #WorldEnvironmentDay #Sustainability #MyGreenLab #MyGreenLabCertified